Skip to content

Study · Animal study (in vivo) · rat · 2014

2 results

Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat.

Vázquez-Roque RA, Ubhi K, Masliah E, Flores G

Synapse (New York, N.Y.)24 Oct 2013Cited by 22 (Europe PMC)

PMID24123373 (opens in a new tab)DOI10.1002/syn.21718 (opens in a new tab)PepBankPUB-24123373
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In nVHL rats, repeated cerebrolysin treatment ameliorated dendritic pathology in the basolateral amygdala.

    In plain wordsIn rats with hippocampal lesions, cerebrolysin reduced dendritic damage in the amygdala.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseDendritic pathology
    Study

    ratn: not reported in source

    neonatal ventral hippocampal lesion
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Interestingly, repeated Cbl treatment ameliorated dendritic pathology and neuronal loss in the BLA of the nVHL rats.
    2 context sentences
    Summary · context
    This study aimed to determine whether Cbl treatment was capable of reducing BLA neuronal alterations observed in nVHL rats.
    Summary · context
    The morphological evaluation included examination of dendrites using the Golgi-Cox procedure and stereology to quantify the total cell number in BLA.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In nVHL rats, repeated cerebrolysin treatment ameliorated neuronal loss in the basolateral amygdala.

    In plain wordsIn rats with hippocampal lesions, cerebrolysin reduced neuron loss in the amygdala.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseNeuronal loss
    Study

    ratn: not reported in source

    neonatal ventral hippocampal lesion
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Interestingly, repeated Cbl treatment ameliorated dendritic pathology and neuronal loss in the BLA of the nVHL rats.
    2 context sentences
    Summary · context
    This study aimed to determine whether Cbl treatment was capable of reducing BLA neuronal alterations observed in nVHL rats.
    Summary · context
    The morphological evaluation included examination of dendrites using the Golgi-Cox procedure and stereology to quantify the total cell number in BLA.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.